Recovery pathway
Wolverine
Proprietary blend
Laboratory verification
Nothing unverified is published
Every compound is prepared to a documented standard. Independent certificates of analysis are published here per batch as they are verified under Nuragen's own governance, we do not reuse another brand's certificates or purity figures.
Certificate of analysis · per batch · on request
Verification-led release
Wolverine is a proprietary multi-component blend formulated around peptides studied in tissue-repair and remodelling research. It is supplied strictly as a research-use-only material for laboratory investigation.
How it is studied
Wolverine is examined in the research literature as a composite formulation, where investigators look at how its combined peptide components behave within the recovery pathway. Studies in this area typically focus on signalling associated with tissue repair and extracellular matrix remodelling, rather than on any single isolated action. Because it is a blend, research interest often centres on how the components are thought to act alongside one another in controlled experimental models. All such work sits within a research context and does not describe use in people or animals.
The components and the pathway
The formulation is described as a proprietary recovery blend, combining peptides that are studied for their association with tissue-repair and remodelling processes. In the literature, peptides of this class are thought to interact with signalling steps involved in cellular repair, angiogenesis and matrix reorganisation. NURAGEN holds the specific composition as a proprietary formulation, so the blend is characterised by the pathway it is grouped under rather than by disclosed ratios. This is a description of what the compound is studied to act on, not a statement of any effect a person would experience.
How it sits in a responsible research programme
Within a structured research programme, a multi-component blend like Wolverine is handled as a defined material with documented storage, handling and labelling. Investigators typically record provenance, conditions and experimental parameters so that observations can be interpreted and, where relevant, reproduced. Framing the material as research-use-only keeps the emphasis on method and evidence rather than on application. This approach reflects our principle of science, made accountable.
Composition
| Component | CAS | Purity |
|---|---|---|
| Proprietary recovery blend | — | Pending |
| Type | Lyophilised powder |
|---|---|
| Presentation | Lyophilised powder |
| Appearance | White lyophilised powder |
| Storage | Store at 2-8°C, protected from light. |
| Dispatch | Delivered within 72 hours across the UK. |
Handling should follow standard laboratory practice and your own institutional protocols. No dosing, administration or medical guidance is provided.
Wolverine is a proprietary multi-component blend of peptides studied within the tissue-repair and remodelling area of the recovery pathway. It is supplied strictly as a research-use-only material for laboratory investigation, and it is not intended for human or animal use of any kind.
As a general guide for peptide research materials, storage at 2-8C and protection from light are commonly specified to help maintain stability. Handling should follow standard laboratory practice for the material and its container. Always defer to the documentation and conditions specified with your particular material.
We provide a factual description of what the compound is and the pathway it is studied in relation to. We do not provide dosing, administration guidance, protocols, or any medical, veterinary or clinical advice, and nothing here should be read as such. Questions about human or animal use fall outside the scope of a research-use-only material.
Wolverine is held as a proprietary formulation, so the specific components and their ratios are not disclosed. It is characterised instead by the recovery pathway it is grouped under and by the tissue-repair and remodelling research its peptide classes are associated with. This lets us describe what the material is studied to act on without stating unverified specifics.
In context
Evidence before action
With a proprietary blend, it can be tempting to reason about the whole from the reputation of its parts, but a combination is not simply the sum of its components. Responsible practice means reading the available research on each peptide class, noting where evidence is preliminary and where mechanisms are only proposed, and treating the blend as its own subject of study. We describe what the components are understood to act on in the literature, and we do not extend those descriptions into claims about outcomes. Letting the evidence lead, rather than the expectation, is what keeps the work accountable.
Related pathways
Explore alongside
Recovery
Repair
A focused research pair of BPC-157 and TB-500, studied within tissue-repair pathways.
£140
Aesthetic
Glow
Research-use blend of BPC-157, TB-500 and GHK-Cu studied in skin-repair pathways.
£170
New
Aesthetic
KLOW
A four-peptide research blend of GHK-Cu, BPC-157, TB-500 and KPV, studied in the aesthetic pathway.
£250
Recovery
Deep Sleep
Research pairing of DSIP and Sermorelin studied within the recovery pathway.
£160